CaliPharms, Inc.
KGET
$0.00
$0.000.00%
09/30/2014 | 06/30/2014 | ||||
---|---|---|---|---|---|
Revenue | 81.82% | 68.37% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 81.82% | 68.37% | |||
Cost of Revenue | 32.68% | 104.84% | |||
Gross Profit | 58.66% | -237.74% | |||
SG&A Expenses | 38.33% | -50.74% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 36.98% | -39.85% | |||
Operating Income | -28.74% | 46.17% | |||
Income Before Tax | -218.95% | -67.35% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -218.95% | -67.35% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -218.95% | -67.35% | |||
EBIT | -28.74% | 46.17% | |||
EBITDA | -- | -- | |||
EPS Basic | -200.00% | -33.33% | |||
Normalized Basic EPS | -300.00% | 0.00% | |||
EPS Diluted | -200.00% | -33.33% | |||
Normalized Diluted EPS | -300.00% | 0.00% | |||
Average Basic Shares Outstanding | 9.24% | 1.02% | |||
Average Diluted Shares Outstanding | 9.24% | 1.02% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |